indications for glp-1 agonists What to know about the new era of drugs GLP-1 receptor agonists are transforming

It does not suggest the same kind of gravitas that the Nobel prize carries

Will tirzepatide cannibalize the entire GLP-1 RA T2D and obesity market

Assuming an initial reduction of 15 % to 20 % of baseline weight, the model suggests that 4 % to 5 % of the remaining weight is lost in the long term

Friedman School of Nutrition Science and Policy at Tufts University, recently served as lead chair and author of a clinical advisory titled Nutritional Priorities to Support GLP-1 Therapy for Obesity, published across four peer-reviewed journals and issued by four leading organizations in lifestyle medicine, obesity medicine, and nutritionthe American College of Lifestyle Medicine (ACLM), the American Society for Nutrition (ASN), the Obesity Medicine Association (OMA), and The Obesity Society (TOS)

The February 20, 2026 FDA action against 30 telehealth companies reshaped the landscape

To mitigate potential confounding variables, we employed PSM, pairing each GLP-1 RAs user with a non-user using a greedy nearest neighbor matching approach integrated within TriNetX